Logo for Structure Therapeutics Inc

Structure Therapeutics Investor Relations Material

Latest events

Logo for Structure Therapeutics Inc

Study Update

Structure Therapeutics
Logo for Structure Therapeutics

Study Update

13 Nov, 2024
Logo for Structure Therapeutics

Q3 2024

13 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Structure Therapeutics Inc

Access all reports
Structure Therapeutics Inc., known by its Nasdaq ticker symbol GPCR, is a clinical-stage global biopharmaceutical company that focuses on designing innovative, orally available small molecule medicines. The company aims to transform the lives of patients worldwide by leveraging advanced computing and structure-based technologies. Its mission is to replace biologics and peptides with small-molecule drugs that offer life-changing solutions. The company is headquartered in San Francisco, California, and its shares are listed on the Nasdaq.